Abstract
Female Breast Cancer (BC) was the leading cause of global Cancer incidence in 2020, accounting for 11.7% of all cancer cases. In Brazil, there is a high prevalence, among young patients, of primary and metastatic tumors. Cancers classified as triple-negative (TNBCs) represent up to 24% of all BC cases, with no therapeutic options aimed at this tumor type. Defined by the absence of hormone…